uprm.edu

MBRS PROGRAM

Home ::

Menu

Home

Webmail

MBRS Overview

SCORE Mechanisms

Projects

Faculty

Advisory Committee

Statistics

Publications

Policy Comply

Progress Report 09-10

Facilities

Download Documents

News

Events

Contact Us

MORE RSS

Error: It's not possible to reach RSS file...

NIH RSS

Notice of Special Interest: Public Policy Effects on Alcohol-, Cannabis-, Tobacco-, and Other Drug-Related Behaviors and Outcomes

Notice of Change in Key Dates for RFA-AI-20-077, Immune Development in Early Life (IDEaL) (U01 Clinical Trial Not Allowed)

NIAID Funded Extensions for Career Award Recipients Whose Career Trajectories Have Been Significantly Impacted by COVID-19

NIAID Funded Extensions for Fellowship Award Recipients Whose Career Trajectories Have Been Significantly Impacted by COVID-19

Notice of Special Interest (NOSI): Biology of Lung and Head and Neck Preneoplasia

Notice of Special Interest (NOSI): Early-life Factors and Cancer Development Later in Life

Notice of Intent to Publish a Funding Opportunity Announcement for Pancreatic Ductal Adenocarcinoma (PDAC) Stromal Reprogramming Consortium (PSRC) (U01 - Clinical Trial Not Allowed)

Notice of Intent to Publish: Pancreatic Ductal Adenocarcinoma Stromal Reprogramming Consortium Coordinating and Data Management Center (PSRC CDMC) (U24 - Clinical Trial Not Allowed)

Notice of Correction of Key Dates for PAR-20-284, Innovative Research in Cancer Nanotechnology (IRCN) (R01 Clinical Trial Not Allowed)

Notice of Pre-Application Webinar for RFA-CA-21-031, Exercise and Nutrition Interventions to Improve Cancer Treatment-Related Outcomes (ENICTO; U01 Clinical Trial Required) and RFA-CA-21-032, (ENICTO Coordinating Center; U24 Clinical Trial Not Allowed)

Notice of NIDA's participation in NOT-NS-21-049, "Notice of Special Interest (NOSI): NIH Research Project Grant (R01) Applications from Individuals from Diverse Backgrounds, Including Under-Represented Minorities"

Notice of NIBIB Participation in PAR-21-166 "Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (R01 - Clinical Trial Not Allowed)"

Notice of NIBIB Participation to PA-20-194 "NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Required)"

Notice of NIBIB Participation to PA-20-195 "NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Not Allowed)"

Notice of Change to NOT-EB-21-005 "NIBIB Guidance for Support of Clinical Trial Applications"

Request for Information (RFI): Drinking Water Contaminants of Emerging Concern for National Emerging Contaminant Research Initiative

Notice of NICHD Participation in RFA-AI-20-078 "Immune Development in Early Life (IDEaL) (U19 Clinical Trial Not Allowed)"

Notice of Special Interest (NOSI): Administrative Supplements to Support Addiction Science and Related Neuroscience Pilot Research Projects at NIMHD-Funded Research Centers in Minority Institutions (RCMI)

Notice of Special Interest (NOSI): NIH Research Project Grant (R01) Applications from Individuals from Diverse Backgrounds, Including Under-Represented Minorities

Notice of Early Termination of PAR-21-159, Limited Competition: Development and Renovation of Research Space for HIV/AIDS Research at Institutions Serving Underrepresented Populations or Located in Institutional Development Award (IDeA)-eligible States (C06 Clinical Trial Not Allowed)

Notice of Change to Additional Information for NOT-OD-21-094 "Notice of Special Interest (NOSI): Administrative Supplements to Support Collaborations to Improve the AI/ML-Readiness of NIH-Supported Data"

Exercise and Nutrition Interventions to Improve Cancer Treatment-Related Outcomes (ENICTO) in Cancer Survivors Consortium (U01 Clinical Trial Required)

Coordinating Center for Exercise and Nutrition Interventions to Improve Cancer Treatment-Related Outcomes (ENICTO) in Cancer Survivors Consortium (U24 Clinical Trial Not Allowed)

Support for Small Business Innovation Research (SBIR) to Develop New Technologies for Development and Integration of Novel Components for Open and Closed Loop Hormone Replacement Platforms for T1D Therapy (R43/R44 Clinical Trial Not Allowed)

Human Milk as a Biological System (R01 Clinical Trial Optional)

NHLBI Outstanding Investigator Award (OIA) (R35 Clinical Trial Optional)

NHLBI Emerging Investigator Award (EIA) (R35 Clinical Trial Optional)

Research Program Award (R35 Clinical Trial Optional)

NeuroNEXT Clinical Trials (U01 Clinical Trial Optional)

NeuroNEXT Small Business Innovation in Clinical Trials (U44 Clinical Trial Optional)

Screening and Functional Validation of Human Birth Defects Genomic Variants (R01 Clinical Trial Not Allowed)

Limited Competition: Development and Renovation of Research Space for HIV/AIDS Research at Institutions Serving Underrepresented Populations or Located in Institutional Development Award (IDeA)-eligible States (C06 Clinical Trial Not Allowed)

MBRS-SCORE at University of Puerto Rico at Mayagüez

University of Puerto Rico at Mayagüez received its first MBRS grant award in 1974. The program has been in continuous operation since that time. In 1999 UPRM was successful in competing for MBRS SCORE Program. The current awards are for four-year periods ending in 2011.

PDF

MBRS-SCORE Organizational Structure

News

NEW

FINAL PROGRESS REPORT.doc "PRELIMINARY DEADLINE MARCH 31, 2011".

NEW

NEW

MBRS FINAL REPORT INSTRUCTIONS.doc

NIH Announces Plans to Transition to the Application and Electronic Submission through Grants.gov

Phone: (787) 834 3165
Fax: (787) 834-3165
e-mail: mbrs[AT]uprm[dot]edu

MBRS-SCORE Program
University of Puerto Rico at Mayagüez
Research and Development Center
Main Building, Office 210
Mayaguez, PR